Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

ScPharmaceuticals

Explore full profile

Clinical-stage company specializing in subcutaneous drug delivery, aiming to replace traditional intravenous (IV) therapies

Burlington, United StatesFounded 2014Biotech & Life Sciences
Valuation $304M Market cap · 2025
Revenue $36M Latest reported FY

About ScPharmaceuticals

scPharmaceuticals is a pharmaceutical company dedicated to developing and commercializing innovative solutions aimed at enhancing outpatient care. The company focuses on creating proprietary subcutaneous furosemide treatments for heart failure (HF) diuresis, delivered via an on-body infusor. This technology allows patients to receive necessary treatments outside of a hospital setting, improving comfort and maintaining dignity during recuperation. scPharmaceuticals primarily serves patients with heart failure, targeting the outpatient care market. The business model revolves around the development and sale of its proprietary drug delivery systems, generating revenue through product sales and potentially through partnerships or licensing agreements. By shifting care from inpatient to outpatient settings, scPharmaceuticals aims to transform disease management and reduce healthcare costs.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2014
Headquarters
Burlington, United States
Listing
IPO 2017
Sector
Biotech & Life Sciences
Power Law
Colt$25–100M revenue

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • 5AM Ventures
  • Lundbeckfonden
  • Lundbeckfonden Ventures
  • Sun Pharmaceutical Industries
  • OrbiMed

Series B and later3 investors entered at this stage

  • Standard Treasury
  • Solar capital
  • Oaktree Capital Management
Employees mapped 40 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 32 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States97.3%
1 country shown
Web traffic by country
120 monthly visits
across markets
🇺🇸 United States83.3%
Top 1 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about ScPharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ScPharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.